Product Information
TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.0845 per ML under NDC 00093408563. Its NADAC has been published 553 times since Nov 18, 2015.
FDA first approved this application on Oct 10, 2013. Its Orange Book therapeutic-equivalence code is AN.
Strength
300 mg/5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093408563
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA091589FDA Approved
10/10/2013
TE Code
AN
On Market Since
11/19/2013
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 553 times since Nov 18, 2015, and over the history we have for it it has declined 92.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0845 per ML |
|---|---|
| All-time high | $14.2842 (Dec 16, 2015) |
| All-time low | $1.0672 (Mar 18, 2026) |
| 52-week high | $1.6501 |
| 52-week low | $1.0672 |
| Median price | $4.6175 |
| Average price | $5.2526 |
| Largest weekly change | -33.9% (Nov 20, 2024) |
| Weeks tracked | 553 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.0845 per ML (NDC 00093408563), effective Aug 19, 2026.
How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 92.4%. It has been tracked across 553 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?
Since Nov 18, 2015, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0672 (Mar 18, 2026) to a high of $14.2842 (Dec 16, 2015), with a median of $4.6175 per ML.
Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 300 MG/5 ML AMPULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?
TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 00093408563) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.